India is no longer building healthcare technology only for India. The five startups below were built or founded in India and are taking healthcare to patients and providers around the world: unifying hospital data, reading scans where radiologists are scarce, catching heart attacks early, delivering mental health support at scale, and connecting patients with care across borders.
1. CureMeAbroad (Pune, India)
CureMeAbroad is a global healthcare platform that owns the entire patient journey, from treatment research and teleconsultation to hospital coordination, travel and post-treatment follow-up. At its core is a proprietary AI engine that discovers and matches hospitals to a patient’s treatment needs, and benchmarks pricing across destinations so patients can compare like for like before they commit. The engine works across a directory of more than 6,000 hospitals in 47 countries and 45 specialties, and it feeds a network of more than 400 accredited hospital partners in destinations including India, Thailand, Turkey, Mexico, South Korea and Georgia. Its dual-tier model is the growth engine: a free AI-led discovery layer brings patients in at scale, and a share converts into a paid white-glove concierge tier. That is how it passed $5 million in annual run rate in its first year and reached cashflow positivity within two quarters, without leaning on paid acquisition. Backed by HIPAA compliance and Global Healthcare Accreditation, CureMeAbroad is now expanding its experience centres to the US and Australia, bringing the platform closer to patients on the ground.
2. Innovaccer (Noida and San Francisco)
Innovaccer was founded in 2014 by Abhinav Shashank, Kanav Hasija and Sandeep Gupta, and the founders paired engineering talent in Noida with a San Francisco headquarters to sell to US hospitals. Its platform takes complex data from every point of care and turns it into insights organisations can act on. It became a healthcare unicorn in 2021 and now pitches itself as an AI-agent cloud for healthcare, having launched its Gravity enterprise AI and data platform in 2025. It has also signed a strategic collaboration agreement with AWS to accelerate agentic AI in healthcare. Innovaccer shows that the unglamorous problem of fragmented hospital data can be solved from India.
3. Qure.ai (Mumbai)
Qure.ai builds AI that helps physicians read X-ray, CT and ultrasound images in under a minute. Its tools are deployed in more than 100 countries, it holds 18 FDA clearances, the most for lung cancer AI in the US, and TIME named it one of the world’s most influential companies in 2025. In February 2026 it won FDA clearance for six more chest X-ray indications, and in January 2026 it received Gates Foundation support to build an open-source lung health database. Closer to home, its AI-based screening was deployed at the Mahakumbh. It focuses on low- and middle-income countries, drawing on experience in tuberculosis surveillance at scale.
4. Tricog Health (Bengaluru)
Founded in 2014 by interventional cardiologist Dr Charit Bhograj, Tricog Health combines connected medical technology, AI, cloud infrastructure and clinical expertise to detect and manage cardiovascular disease faster. The company says its platforms have screened more than 40 million patients, identified over 500,000 heart attacks and flagged nearly 1.5 million critical ECG findings, supporting 12,000+ customers across 15,000+ installations. It has expanded beyond acute ECG diagnosis into AI-assisted echocardiography, cardiovascular risk stratification and remote monitoring, and in September 2026 it presented its platform to Prime Minister Narendra Modi, President Putin, President Xi and other leaders at the BRICS Bharat Innovates Exposition. Its idea is that specialist expertise should reach the patient digitally when the specialist cannot.
5. Wysa (Bengaluru)
Wysa is developed in India and marketed globally. Its AI-led mental health platform is used by more than seven million people across 105 countries and works with the UK’s NHS, Singapore’s Ministry of Health and public health programmes in India. In the NHS, its digital referral assistant has been used by over 117,000 patients across 31 Talking Therapy services since 2022. It has achieved FDA Breakthrough Device Designation for an AI agent for adults with chronic musculoskeletal pain and associated depression and anxiety, and in 2026 it was named a Top 10 winner of the AI for All: Global Impact Challenge at the India AI Impact Summit, chosen from over 1,350 applications across 60 countries.
****
